Transforming growth factor-β1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma.
about
Cancer stem cells (CSCs), cervical CSCs and targeted therapiesEpithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumorsThe BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsProtein Markers Associated with an ALDH Sub-Population in Colorectal Cancer.Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation.A novel role of hepatic epithelial transforming growth factor-β signaling in cholangiocarcinogenesis.Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells.Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem CellsBIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes.Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?Effects of PTEN gene silencing on invasion and EMT in oral squamous carcinoma Tca8113 cells.Causes and consequences of nuclear envelope alterations in tumour progression.Isolation, identification, and characterization of cancer stem cells: A review.Biliary tract cancer stem cells - translational options and challenges.CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway.APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death.TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures.Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells.Regenerative potential of human schneiderian membrane: progenitor cells and epithelial-mesenchymal transition.Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor-Dependent Signaling.Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state.PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation.LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients
P2860
Q26747144-F1840D7F-1A92-470D-A8C8-A68AEA2B3329Q26771988-C01D140F-1AC3-49F9-A9D5-F686A5F551E5Q26786476-A332CEC4-6D4F-4EC1-9066-6CC53EB10168Q27340125-59ED9910-C26B-4373-83BD-EBB586BAD5ACQ36371449-A8DDB8C5-C26E-421B-BD47-4103648705EBQ36591967-80FED4B1-8094-4596-8700-D31A069DAFEFQ36685703-0FD859AA-917A-433A-9DB9-565F760373CAQ37020145-64E4D304-FFEE-4AFC-A4C7-7D764191860BQ37020846-569B8107-E7A7-4C75-B9BD-2F3F5AB67AF9Q37376452-D4B71ECD-EC34-4A28-A74D-A5B95E723C8DQ38584340-7F776ACD-E35D-4F49-AAF1-D32880ECD43FQ38748416-E4A94437-4413-41CF-943A-E234AC1DBF1DQ38891711-0C73FC11-8E31-4595-AE65-22CEEFAC7359Q39055537-13784ABD-3479-4652-8634-E8EA87DCF8ABQ39279276-E2546A0B-F8D5-46E4-82B4-A63145CC6E0CQ41546447-71B2555F-2E43-4EAC-A65C-A231B44EB045Q41552553-63CAC9A3-0504-4FCC-A138-07598940D4A4Q41617837-87799E4B-B7D6-43A5-A664-188FF6C8055BQ41660971-536149C2-CD13-40EE-96BA-FF2D949FFEB8Q46662773-5C561C7C-B9BC-436A-B800-2790044D4391Q47099304-4048E8A6-B34D-48DF-8180-F4CEB0F35792Q47130831-9E271FF7-ADEA-41D4-9324-9437CB2F078EQ52685835-45E76F9E-DA83-4348-BCA5-AC2423F54819Q58747071-3B0D4523-5AE1-4237-A30D-5E6A85F08D66
P2860
Transforming growth factor-β1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Transforming growth factor-β1- ...... perties in cholangiocarcinoma.
@en
type
label
Transforming growth factor-β1- ...... perties in cholangiocarcinoma.
@en
prefLabel
Transforming growth factor-β1- ...... perties in cholangiocarcinoma.
@en
P2093
P1433
P1476
Transforming growth factor-β1- ...... operties in cholangiocarcinoma
@en
P2093
Shengping Li
Wen-Chao Wu
Yong-Cheng Liu
Ze-Yu Shuang
P304
P356
10.1016/J.CANLET.2014.08.030
P407
P577
2014-09-03T00:00:00Z